Ginkgo Bioworks Holdings (NYSE:DNA) just reported results for the second quarter of 2024.
- Ginkgo Bioworks Holdings reported earnings per share of -11 cents. This was below the analyst estimate for EPS of -8 cents.
- The company reported revenue of $56.21 million.
- This was 28.59% better than the analyst estimate for revenue of $43.71 million.